Acer Therapeutics Inc (NASDAQ:ACER)

5.17
Delayed Data
As of 11:59am ET
 +0.225 / +4.55%
Today’s Change
1.87
Today|||52-Week Range
28.25
+28.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization4.8K5.6K11.1K9.5K
 
 
 
 
 
 
Operating ExpensesGross Income-4.8K-5.6K-11.1K-9.5K
 
 
 
 
 
General Expenses4.9M4.1M8.7M8.2M
 
 
 
 
 
Research And Development2.7M2.4M5.3M3.9M
 
 
 
 
 
Total Operating Expenses4.9M4.1M8.7M8.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-4.1M-8.7M-8.2M
 
 
 
 
 
Interest Expense On Debt0.000.00987.000.00
 
 
Other Expenses44.1K3.2K-3.4K23.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.8M-4.0M-8.5M-8.0M
 
 
 
 
 
Net Income-4.8M-4.0M-8.5M-8.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.5M9.1M10.1M10.1M
 
 
 
 
 
Shares To Calculate EPS Diluted7.5M9.1M10.1M10.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.64-$0.43-$0.85-$0.79
 
 
 
 
 
EPS Diluted-$0.64-$0.43-$0.85-$0.79